Scientist.com Named to Inc. 500 List for Third Consecutive Year With Three-Year Revenue Growth of 1,522%

News
2019
2018
Archive

July 19, 2019

Pear Therapeutics Announces FDA Submission for SOMRYST™, a Prescription Digital Therapeutic for the Treatment of Adults with Chronic Insomnia and Depression
July 18, 2019

Rallybio Expands Drug Development Team with Addition of Ann Willauer, PMP
July 18, 2019

Escient Pharmaceuticals Appoints Kristin Taylor, PhD as Vice President and Head of Clinical Development
July 18, 2019

Autoimmune Clinical Drug Development Expert, David J. Chang, M.D., M.P.H., Joins Cabaletta Bio as Chief Medical Officer
July 16, 2019

Homology Medicines Appoints Alise Reicin, MD, to the Board of Directors
July 12, 2019

IDEAYA Biosciences Announces First Patient Dosing of PKC inhibitor IDE196 in Phase 1/2 Tissue-Type Agnostic Basket Trial for Solid Tumors Harboring GNAQ or GNA11 Mutations
July 12, 2019

Kinestral Technologies’ Halio Cloud Becomes the First Globally Deployed Smart Window Control System
June 25, 2019

Arvinas Receives Authorization to Proceed for ARV-471, a PROTAC® Protein Degrader to Treat Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer
June 20, 2019

Nouscom Demonstrates Preclinical Proof of Concept for Personalized Cancer Neoantigen Vaccine in Combination with Immune Checkpoint Blockade to Eradicate Large Tumors
June 20, 2019

Entrada Therapeutics Appoints John F. Crowley to Board of Directors